Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Director sold 29,705 shares at $4.50 ($133,673)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Director bought 6,800 shares at $3.68 ($25,024)
  9. 4 Open-market sale Director sold 25,000 shares at $3.25 ($81,250)
  10. 4 Open-market sale CEO and Director sold 125,000 shares at an average $3.25 ($406,788)
  11. 4 Open-market sale Director sold 11,987 shares at $3.27 ($39,197)
  12. 4 Open-market sale Director sold 50,000 shares at $3.28 ($164,000)
  13. 4 Exercise or conversion Director acquired 397,500 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 24 · 475 filings